Position in LGND
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$232,392
New position
Shares Held
1,164
first reported quarter
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026SCOTIA CAPITAL INC. holds $18,289,216 across 14 Biotechnology names. LGND ranks #7 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EPRX |
Eupraxia Pharmaceuticals Inc.
|
1,342,178 | $9,717,368 | |
| 2 | BNTX |
BioNTech SE
|
45,000 | $3,999,600 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,861 | $2,170,630 | |
| 4 | DFTX |
Definium Therapeutics, Inc.
|
40,548 | $766,357 | |
| 5 | EYPT |
EyePoint, Inc.
|
41,751 | $538,170 | |
| 6 | LXRX |
Lexicon Pharmaceuticals, Inc.
|
159,831 | $249,336 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
This page
|
1,164 | $232,392 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
7,048 | $229,341 |
All Filings in LGND
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $232,392 | 1,164 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||